Anxiolytic and hypnotic drug misuse in Thailand: Findings from a national household survey

Drug and Alcohol Review

Volumn 29, Issue 1, 2010, Pages 101-111

  Assanangkornchai, Sawitri ^a   Sam Angsri, Nisan ^a   Rerngpongpan, Sirinporn ^b   Edwards, J Guy ^a,c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b ASSUMPTION UNIVERSITY   (Thailand)

^c ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Anxiolytics; Drug misuse; Hypnotics; Prevalence; Thailand

Indexed keywords

ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT;

ADDICTION; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HEALTH STATUS; HUMAN; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; THAILAND;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-ANXIETY AGENTS; CHILD; FEMALE; HEALTH STATUS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; THAILAND; YOUNG ADULT;

EID: 77149126720     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00092.x     Document Type: Article

References (48)

1. Edwards JG, Cantopher T, Olivieri S. Dependence on psychotropic drugs: an overview. Postgrad Med J 1984; 60(Suppl. 2): 29-40.
2. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998;51:273-83.
3. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817-25.
4. Paulose-Ram R, Jonas BS, Orwig D, Safran MA. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2004;57:309-17.
5. Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:1062-73.
6. McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007; 102:1920-30.
7. Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004;39:1-23.
8. Simoni-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. Am J Public Health 2004;94:266-8.
9. Perngparn U. An evaluation of the prevention and control programs for AIDS among patients of the substance treatment centers. Bangkok: Drug Dependence Research Center, Chulalongkorn University, 2005.
10. Assanangkornchai S, Chittrakarn S. Situational review of prescription drug abuse between 2000 and 2004. In: Poshyachinda V, Perngparn U, eds. Situational review of substance-related problems in Thailand between 2000 and 2004. Bangkok: Drug Dependence Research Center, Chulalongkorn University, 2000:105-36.
11. Office of Narcotics Control Board. Statistics of the indictments and seizures of psychotropic drugs between 2000 and 2004. Bangkok: Ministry of Justice, 2005.
12. Administrative Committee on Substance Abuse Research Network. Status of substance use 2001: national household survey, estimation of population related with substance abuse. Bangkok: Drug Dependence Research Center, Institute of Health Research, Chulalongkorn University, 2002.
13. Administrative Committee on Substance Abuse Research Network. Status of substance use 2003: national household survey, estimation of population related with substance abuse. Bangkok: Drug Dependence Research Center, Institute of Health Research, Chulalongkorn University, 2004.
14. Administrative Committee on Substance Abuse Research Network. National Household Survey of Substance use, 2007. Bangkok: Office of the Narcotics Control Board, 2008.
15. Johnston L. General population surveys of drug abuse. In: Mental Health and Substance Dependence Department, ed. Guide to drug abuse epidemiology (WHO/MSD/MSB 00.3). Geneva: World Health Organization, 2000:125-69.
16. Johnston LD, O'Malley PM. Issues of validity and population coverage in student surveys of drug use. NIDA Res Monogr 1985;57:31-54.
17. O'Malley PM, Bachman JG, Johnston LD. Reliability and consistency in self-reports of drug use. Int J Addict 1983; 18:805-24.
18. McCabe SE. Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Arch Pediatr Adolesc Med 2008;162:225-31.
19. McCabe SE. Misperceptions of non-medical prescription drug use: a web survey of college students. Addict Behav 2008;33:713-24.
20. Galduroz JC, Noto AR, Nappo SA, Carlini EA. Household survey on drug abuse in Brazil: study involving the 107 major cities of the country-2001. Addict Behav 2005;30: 545-56.
21. Sareen J, Enns MW, Cox BJ. Potential for misuse of sedatives. Am J Psychiatry 2004;161:1722-3.
22. Goodwin RD, Hasin DS. Sedative use and misuse in the United States. Addiction 2002;97:555-62.
23. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20.Cat. no. PHE 98. 2008 [cited 2009 March 20]; Available from: http://www.aihw.gov.au/publications/phe/ndshs07-fr/ndshs07-fr-no-questio nnaire.pdf.
24. Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging 2006;23:271-87.
25. French DD, Campbell R, Spehar A, Cunningham F, Bulat T, Luther SL. Drugs and falls in community-dwelling older people: a national veterans study. Clin Ther 2006;28:619-30.
26. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007;62:1172-81.
27. Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008;25:61-70.
28. Turner C, Handford AD, Nicholson AN. Sedation and memory: studies with a histamine H-1 receptor antagonist. J Psychopharmacol 2006;20:506-17.
29. Assanangkornchai S, Aramrattana A, Perngparn U, et al. Current situation of substance-related problems in Thailand. J Psychiatr Assoc Thailand 2008;53:24S-36S.
30. Assanangkornchai S, Muekthong A, Sam-Angsri N, Pattanasattayawong U. The use of mitragynine speciosa ('Krathom'), an addictive plant, in Thailand. Subst Use Misuse 2007;42:2145-57.
31. Matzger H, Weisner C. Nonmedical use of prescription drugs among a longitudinal sample of dependent and problem drinkers. Drug Alcohol Depend 2007;86:222-9.
32. Edwards JG. Unwanted effects of psychotropic drugs: 1. effects on human physiological systems, mechanisms and methods of assessment. In: King D, ed. Seminars in clinical psychopharmacology. London: Gaskell, 2004:573-600.
33. Edwards JG. Unwanted effects of psychotropic drugs: 2. drug interactions, effects during pregnancy and breastfeeding, pharmaco-vigilance and medico-legal considerations. In: King D, ed. Seminars in clinical psychopharmacology. London: Gaskell, 2004:601-60.
34. Busto U, Sellers EM, Naranjo CA, Cappell HD, Sanchez-Craig M, Simpkins J. Patterns of benzodiazepine abuse and dependence. Br J Addiction 1986;81:87-94.
35. Edwards JG, Cantopher T, Olivieri S. Benzodiazepine dependence and the problems of withdrawal. Postgrad Med J 1990;66(Suppl. 2): S27-35.
36. Hallstrom C, Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry 1981;16:235-44.
37. Owen RT, Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs 1983;25:385-98.
38. Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. Br Med J 1981;283:643-5.
39. Rickels K, Case GW, Winokur A, Swenson C. Long-term benzodiazepine therapy: benefits and risks. Psychopharmacol Bull 1984;20:608-15.
40. Roy-Byrne PP, Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med 1988;84:1041-52.
41. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983;1:1402-6.
42. Office of Food and Drug Administrative Board. Supply of psychotropic drugs for use in medical practices between 2000-2004. Bangkok: Ministry of Public Health, 2005.
43. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007;369:1047-53.
44. Office of Narcotics Control Board. Summary of the news on important seizures of drugs. 2005; [cited 2005 March 20]; Available from: http://www1.oncb.go.th/document/c2-work19-1-04051101.htm.
45. United States of America Food and Drug Administration. FDA/US Customs import blitz exams reveal potentially dangerous import drug shipments. FDA News 2003;29 September, 2003.
46. The National Center on Addiction and Substance Abuse at Columbia University. 'You've Got Drugs!' Prescription Drug Pushers on the Internet: 2006 Update. CASA White Paper 2006; June 13 2006.
47. Central Narcotics Bureau S. Largest Erimin-5 seizure this year! 2006 28-Jun-2006 [cited 2008 August 19]; Available from: http://www.cnb.gov.sg/Newsroom/index.asp?name=TmV3c3Jvb20gLSBPcGVyYXRpb2 5z&year=MjAwNg&page=NjY4&type=Q3VycmVudA.
48. Olivieri S, Cantopher T, Edwards JG. Two hundred years of dependence on antianxiety drugs. Hum Psychopharmacol 1986;1:117-23.